3D Systems VSP Bolus Made to Optimize Radiotherapy Targeting

3D printing of the patient-specific shape reduces air gaps and improves efficacy of treatment, according to 3D Systems.

3D printing of the patient-specific shape reduces air gaps and improves efficacy of treatment, according to 3D Systems.

VSP Bolus offers a full design and production service based on the patient’s treatment plan. Image courtesy of 3D Systems.


3D Systems has made its entrance into the radiation oncology market with FDA 510(k) clearance of VSP Bolus, a solution designed to deliver patient-specific radiotherapy treatment accessories. As the latest addition to the company’s VSP portfolio of personalized medical devices, VSP Bolus offers a full design and production service based on the patient’s treatment plan.

3D Systems’ experience in additive manufacturing of medical devices enables the company to deliver 3D-printed, biocompatible patient-specific boluses that can improve therapy modulation as well as patient comfort, the company reports.

Approximately 50% of patients diagnosed with cancer will receive radiotherapy as part of their treatment, according to 3D Systems. To help target radiation during treatment, a provider (e.g., medical physicist, dosimetrist, radiation oncologist) will use a bolus—a flexible device that conforms to the patient’s skin.

With VSP Bolus, 3D Systems can design and deliver boluses that conform to a wide range of anatomies. The process begins with the patient’s imaging data and input from the radiotherapy professional. Using this information, VSP Bolus is designed at the requested material thickness to optimize the radiotherapy targeting.

Once designed, 3D Systems’ engineers employ the company’s additive manufacturing solutions to produce a bolus from a soft material that contours to the patient’s anatomy, enabling more efficacious treatment and a more comfortable experience, according to the company.

“Our new VSP Bolus product expands our capabilities to address yet another incredibly important application for personalized healthcare,” says Menno Ellis, executive vice president, healthcare solutions, 3D Systems. “Blending the experience of our biomedical engineers, our biocompatible materials, 3D printing technology, and best-in-class digital workflows, we are able to both design and produce patient-specific devices to help improve the delivery of radiotherapy treatment.”

Sources: Press materials received from the company and additional information gleaned from the company’s website.

More 3D Systems Coverage

Save Time and Reduce Costs with NoSupports™ Metal Printing
Metal 3D printing is a high energy process in which it is possible for unmanaged heat and stress to build up and impact part quality, this guide presents a step-by-step methodology for how to apply NoSupports to a hot end...
Editor’s Pick: Copper-nickel alloy for corrosive environments
CuNi30 enables additive manufacturing of traditionally cast parts.
3D Systems Has Formed New Biotech Company
Systemic Bio company is intended to accelerate drug discovery and development.
3D Systems Offers Copper-Nickel Alloy for Laser Powder Bed Fusion
Material to be commercially available to address existing need for copper-nickel casting alternatives in marine, offshore oil & gas, and chemical & nuclear industries, according to 3D Systems.
3D Systems Ramps Up Production-Scale AM
Acquisition of dp polar delivers a patented, continuous printing process tuned for large-scale production.
Point-of-Care AM Propels Patient Care
3D printing can unleash a new generation of patient-specific medical devices, but regulatory and skills challenges persist as hospitals explore expansion into point-of-care (PoC) manufacturing.
3D Systems Company Profile

Share This Article

Subscribe to our FREE magazine, FREE email newsletters or both!

Join over 90,000 engineering professionals who get fresh engineering news as soon as it is published.




About the Author

DE Editors's avatar
DE Editors

DE’s editors contribute news and new product announcements to Digital Engineering.
Press releases may be sent to them via DE-Editors@digitaleng.news.

Follow DE
#26334